Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up.

ABSTRACT:

Background

With the increasing use of anti-TNF therapy in inflammatory bowel disease (IBD), a shift of costs has been observed with medication costs replacing hospitalization and surgery as major cost driver. We aimed to explore the evolution of IBD-related costs over two years of follow-up.

Methods and findings

In total 1,307 Crohn's disease (CD) patients and 915 ulcerative colitis (UC) patients were prospectively followed for two years by three-monthly web-based questionnaires. Changes of healthcare costs, productivity costs and out-of-pocket costs over time were assessed using mixed model analysis. Multivariable logistic regression analysis was used to identify costs drivers. In total 737 CD patients and 566 UC were included. Total costs were stable over two years of foll

SUBMITTER: van der Valk ME 

PROVIDER: S-EPMC4839678 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature